MediWound Statistics
Total Valuation
MediWound has a market cap or net worth of $215.60 million. The enterprise value is $173.35 million.
Important Dates
The next estimated earnings date is Wednesday, May 20, 2026, before market open.
| Earnings Date | May 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MediWound has 12.85 million shares outstanding. The number of shares has increased by 14.23% in one year.
| Current Share Class | 12.85M |
| Shares Outstanding | 12.85M |
| Shares Change (YoY) | +14.23% |
| Shares Change (QoQ) | +16.36% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 52.14% |
| Float | 9.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.84 |
| Forward PS | 8.46 |
| PB Ratio | 4.86 |
| P/TBV Ratio | 4.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.20.
| Current Ratio | 2.33 |
| Quick Ratio | 2.16 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -40.43 |
Financial Efficiency
Return on equity (ROE) is -63.86% and return on invested capital (ROIC) is -34.90%.
| Return on Equity (ROE) | -63.86% |
| Return on Assets (ROA) | -19.77% |
| Return on Invested Capital (ROIC) | -34.90% |
| Return on Capital Employed (ROCE) | -41.73% |
| Weighted Average Cost of Capital (WACC) | 5.11% |
| Revenue Per Employee | $140,157 |
| Profits Per Employee | -$197,347 |
| Employee Count | 121 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 4.04 |
Taxes
In the past 12 months, MediWound has paid $169,000 in taxes.
| Income Tax | 169,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.06% in the last 52 weeks. The beta is 0.15, so MediWound's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +12.06% |
| 50-Day Moving Average | 17.22 |
| 200-Day Moving Average | 18.06 |
| Relative Strength Index (RSI) | 50.37 |
| Average Volume (20 Days) | 96,022 |
Short Selling Information
The latest short interest is 1.39 million, so 12.32% of the outstanding shares have been sold short.
| Short Interest | 1.39M |
| Short Previous Month | 1.39M |
| Short % of Shares Out | 12.32% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 17.05 |
Income Statement
In the last 12 months, MediWound had revenue of $16.96 million and -$23.88 million in losses. Loss per share was -$2.10.
| Revenue | 16.96M |
| Gross Profit | 3.25M |
| Operating Income | -25.27M |
| Pretax Income | -23.71M |
| Net Income | -23.88M |
| EBITDA | -24.28M |
| EBIT | -25.27M |
| Loss Per Share | -$2.10 |
Full Income StatementBalance Sheet
The company has $53.14 million in cash and $8.78 million in debt, with a net cash position of $44.37 million or $3.45 per share.
| Cash & Cash Equivalents | 53.14M |
| Total Debt | 8.78M |
| Net Cash | 44.37M |
| Net Cash Per Share | $3.45 |
| Equity (Book Value) | 43.63M |
| Book Value Per Share | 3.40 |
| Working Capital | 34.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.12 million and capital expenditures -$5.51 million, giving a free cash flow of -$21.63 million.
| Operating Cash Flow | -16.12M |
| Capital Expenditures | -5.51M |
| Depreciation & Amortization | 986,000 |
| Net Borrowing | -1.21M |
| Free Cash Flow | -21.63M |
| FCF Per Share | -$1.68 |
Full Cash Flow StatementMargins
Gross margin is 19.19%, with operating and profit margins of -148.98% and -140.80%.
| Gross Margin | 19.19% |
| Operating Margin | -148.98% |
| Pretax Margin | -139.81% |
| Profit Margin | -140.80% |
| EBITDA Margin | -143.17% |
| EBIT Margin | -148.98% |
| FCF Margin | n/a |
Dividends & Yields
MediWound does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.23% |
| Shareholder Yield | -14.23% |
| Earnings Yield | -10.97% |
| FCF Yield | -9.93% |
Analyst Forecast
The average price target for MediWound is $36.00, which is 114.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.00 |
| Price Target Difference | 114.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 60.55% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 20, 2022. It was a reverse split with a ratio of 1:7.
| Last Split Date | Dec 20, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
MediWound has an Altman Z-Score of -1.08 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.08 |
| Piotroski F-Score | 3 |
